Medicamen Organics Ltd IPO: Review, Valuation, Date & GMP

Medicamen Organics Limited IPO: Complete Overview

India is the world's largest generic drug provider, with a reputation for producing low-cost vaccines and generic medications. Over the previous nine years, the Indian pharmaceutical business has grown at a CAGR of 9.43%, making it the third largest producer by volume.

Dear readers today we are ready with IPO details of Medicamen Organics Limited IPO. Medicamen Organics Limited, founded in 1995, develops, manufactures, and distributes pharmaceutical dosages, including generic dosages, in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders for the government (including state and federal governments) and private entities as a contract manufacturer/third-party manufacturer. It is located in New Delhi, India.

The company's product line includes 84 different drugs, including antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral, and nonsteroidal anti-inflammatory drugs (NSAIDs). Medicamen Organics Limited develops, manufactures, and distributes a wide range of pharmaceutical dosages, including generic doses in the form of tablets, capsules, oral liquids, ointments, gel, syrups, suspensions, and dry powders for government (including both 

By September 30, 2023, the company had 116 employees.

The company is all set to offer its IPO on June 21, 2024, So whoever is interested, can take part in the upcoming Medicamen Organics Limited IPO.

Now we will discuss this IPO's offerings in detail below. 

 

Medicamen Organics Limited IPO Overview

The Medicamen Organics Limited IPO is a book-built offering worth 10.54 crore. The issue is a total new issue of 31 lakh shares worth up to Rs.10.54 crore. The IPO will begin subscriptions on June 21, 2024, and end on June 25, 2024. Medicamen Organics Limited IPO will be placed on NSE and SME, with a preliminary listing date set for Friday, June 28, 2024.

The price of each share is Rs.32 to Rs.34.

 

 

 

Company Financial

This is a synopsis of Medicamen Organics Limited IPO's financial data for the financial year that concluded on 31 March 2023 and 31 March 2022.

• Medicamen Organics Limited's revenue increased by 8.38%.

• The company’s PAT rose by 937.7%.

• The total income of the company has increased to 2296.24 lacs from 2118.67 lacs.
  
  

(Amount in Lacs)

Period	30 Sep 2023	31 Mar 2023	31 Mar 2022
Total Assets	3,450.88	3,211.98	2,707.21
Total Revenue	1,132.60	2,296.24	2,118.67
PAT	129.11	95.78	9.23
Net worth	1,180.83	851.71	755.92
Reserve & Surplus	380.83	251.71	155.92
Total Borrowings	1,062.50	1,179.50	1,024.57

 

Revenue Bifurcation

Below are the facts presented in different activities of the company. Let’s have a view on it for a better understanding of the company’s performance.

Cash Flow from Operating Activities:

Net cash flow from operating activities decreased to 48.76 lacs in September 2023, from 58.37 lacs in March 2023.

Cash Flow from Investing Activities:

Net cash involved in investing activities decreased to 6.51 lacs in September 2023, from 28.13 lacs in March 2023.

Cash Flow from Financing Activities:

Net cash flow involved in financing activities decreased to 51.65 lacs in September 2023, from 93.69 lacs in March 2023.

 

 

 Product-wise Revenue Bifurcation

Products	30 Sep 2023	31 Mar 2023	31 March 2022
	Sales (%)	Sales (%)	Sales (%)
Capsules	1.47	22.50	4.18
Ointment	0.36	13.44	17.38
Suspension	21.43	0.65	2.53
Dry Powder Sachet	2.88	7.00	1.60
Tablet	64.80	49.98	71.74
Other Operating Revenues	9.06	6.43	2.57

 

The Objective of the Issue

The company desires to use the Net Proceeds from the Issue to fulfill:

• Product registration in international markets,

• Plant enhancements and increased production activity.

• Working capital requirements, and 

• General corporate purposes.

 

Peers of Medicamen Organics Limited IPO

(Rs. in Lacs)

Company Name	Face Value (Rs.)	EPS (Rs.)	P/E
Brooks Laboratories Ltd	10	12.57	10.60
Cian Healthcare Ltd	10	0.43	53.84
Zenotech Laboratories Ltd	10	1.90	38.76

 

Evaluation

The IPO issue price is Rs.32 to Rs.34 for each share.

Evaluation of P/E Ratio

The P/E Ratio of Medicamen Organics Limited IPO is not available.

 

 

Comparative Analysis with Listed Peers

The average P/E Ratio of the industry is not available.

 

IPO's Strengths

• Experienced promoter and management team.

• Diverse product portfolio.

• Scalable business model.

• Ensuring quality

 

IPO’s Weaknesses 

• Dependency on buyers

• Lack of brand awareness

• Lack of firm arrangements for Finance

 

IPO GMP Today

The Latest GMP of Medicamen Organics Limited IPO is Rs.55

 

Medicamen Organics Limited IPO timetable (Tentative)

Medicamen Organics Limited IPO is scheduled from June 21 to June 25, 2024, with allotment on June 26, refund initiation on June 27, and listing on June 28, 2024.

Events	Date
IPO Opening Date	June 21, 2024
IPO Closing Date	June 25, 2024
IPO Allotment Date	June 26, 2024
Refund initiation	June 27, 2024
IPO Listing Date	June 28, 2024

 

Medicamen Organics Limited IPO Details 

Medicamen Organics Limited IPO with a face value of Rs.10 per share is set to start on June 21 and close on 25 June and will offer a fresh issue size of 3,100,000 shares (worth up to ₹10.54 Cr).

IPO Opening & Closing Date	June 21, 2024 to June 25, 2024
Face Value	Rs.10 per share
Issue Price	Rs.32 to Rs.34
Lot Size	4000 shares
Price of 1 lot	Rs. 1,36,000
Issue Size	3,100,000 shares (aggregating up to ₹10.54 Cr)
Offer for sale	Nil
Fresh Issue	3,100,000 shares (aggregating up to ₹10.54 Cr)
Listing at	NSE, SME
Issue Type	Book Built Issue IPO
Registrar	Kfin Technologies Limited

 

 

 

Medicamen Organics Limited IPO Lot Details 

Medicamen Organics Limited IPO allows retail investors to invest in a minimum and maximum of 1 lot (4000 shares) at Rs.1,36,000 while for HNI investors, the minimum lot is 2 (8000 shares) at Rs.2,72,000.

Minimum Lot Investment (Retail)	1 lot
Maximum Lot Investment (Retail)	1 lot
HNI (Min)	2 lot

 

Medicamen Organics Limited IPO Reservation

QIB share Portion	50%
Retail Investors’ Share Portion	35%
NII (HNI) shares offered	15%

 

Promoters and Management of Medicamen Organics Limited IPO

• Mr. Bal Kishan Gupta

 Medicamen Organics Limited IPO Lead Managers

• GYR Capital Advisors Private Limited

 

Dividend Policy

The company has not paid any Dividends in the last 3 years.

 Conclusion

Medicamen Organics Limited IPO has previously experienced negative cash flows from investing and financing activities in the period that ended 31 March 2023, and 31 March 2022.

So, if you want to participate in its upcoming IPO, you need first conduct extensive research on the company, its finances, commercial prospects, and industry trends.

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

 

Disclaimer: This IPO analysis is only for informational purposes and should not be considered as investment advice. Always do your research and consult with a financial advisor.

Want to start Your Journey in stock market trading and investment? Join our Stock Market Class to become beginner to expert trader! We cover everything from the basics of trading to advanced strategies for picking stocks. Plus, we're offering a special discount for women and students. Don't miss out - enroll now and kickstart your path to success in the stock market!

Open a world of Stock Market by Opening a Demat Account with your favourite Broking firm & Get a trading Strategy worth Rs.15,000!

• AngelOne
• Zerodha
• Upstox
• Alice Blue

Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.

Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock market.